Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter September 4, 2019

The effects of soy on scopolamine-induced spatial learning and memory impairments are comparable to the effects of estradiol

  • Narges Marefati , Amin Mokhtari-Zaer , Farimah Beheshti , Sareh Karimi , Zahra Mahdian , Mehdi Khodamoradi and Mahmoud Hosseini EMAIL logo

Abstract

Background

Modulatory effects of soy extract and estradiol on the central nervous system (CNS) have been reported. The effect of soy on scopolamine-induced spatial learning and memory in comparison to the effect of estradiol was investigated.

Materials and methods

Ovariectomized rats were divided into the following groups: (1) control, (2) scopolamine (Sco), (3) scopolamine-soy 20 (Sco-S 20), (4) scopolamine-soy 60 (Sco-S 60), (5) scopolamine-estradiol 20 (Sco-E 20) and (6) scopolamine-estradiol 60 (Sco-E 60). Soy extract, estradiol and vehicle were administered daily for 6 weeks before training in the Morris water maze (MWM) test. Scopolamine (2 mg/kg) was injected 30 min before training in the MWM test.

Results

In the MWM, the escape latency and traveled path to find the platform in the Sco group was prolonged compared to the control group (p < 0.001). Treatment by higher doses of soy improved performances of the rats in the MWM (p < 0.05 – p < 0.001). However, treatment with both doses of estradiol (20 and 60 μg/kg) resulted in a statistically significant improvement in the MWM (p < 0.01 – p < 0.001). Cortical, hippocampal and serum levels of malondialdehyde (MDA), as an index of lipid peroxidation, were increased which was prevented by soy extract and estradiol (p < 0.001). Cortical, hippocampal as well as serum levels of the total thiol, superoxide dismutase (SOD) and catalase (CAT) in Sco group were lower than the control group (p < 0.001) while they were enhanced when the animals were treated by soy extract and estradiol (p < 0.01 – p < 0.001).

Conclusions

It was observed that both soy extract and estradiol prevented learning and memory impairments induced by scopolamine in ovariectomized rats. These effects can be attributed to their protective effects on oxidative damage of the brain tissue.

Acknowledgments

The authors appreciate the Vice Chancellor for Research and Technology, Mashhad University of Medical Sciences for financial support.

Author Statement

  1. Research funding: None declared.

  2. Conflict of interest: The author declares that there is no conflict of interest regarding the publication of this paper

  3. Informed consent: Not applicable.

  4. Ethical approval: Animal procedures were carried out in accordance with the Guide for the Care and Use of Laboratory Animals and were approved by the Committee on Animal Research of Mashhad University of Medical Sciences. The document number was 941168.

References

[1] Folch J, Petrov D, Ettcheto M, Abad S, Sanchez-Lopez E, Garcia ML, et al. Current research therapeutic strategies for Alzheimer’s disease treatment. Neural Plast. 2016;2016:8501693.10.1155/2016/8501693Search in Google Scholar PubMed

[2] Christensen A, Pike CJ. Menopause, obesity and inflammation: interactive risk factors for Alzheimer’s disease. Front Aging Neurosci. 2015;7:130.10.3389/fnagi.2015.00130Search in Google Scholar PubMed

[3] Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119–22.10.1001/archneur.60.8.1119Search in Google Scholar PubMed

[4] Newhouse P, Dumas J. Estrogen-cholinergic interactions: implications for cognitive aging. Horm Behav. 2015;74:173–85.10.1016/j.yhbeh.2015.06.022Search in Google Scholar PubMed

[5] Shen J, Wu J. Nicotinic cholinergic mechanisms in Alzheimer’s disease. Int Rev Neurobiol. 2015;124:275–92.10.1016/bs.irn.2015.08.002Search in Google Scholar PubMed

[6] Verdile G, Laws SM, Henley D, Ames D, Bush AI, Ellis KA, et al. Associations between gonadotropins, testosterone and beta amyloid in men at risk of Alzheimer’s disease. Mol Psychiatry. 2014;19:69–75.10.1038/mp.2012.147Search in Google Scholar PubMed

[7] Short RA, Bowen RL, O’Brien PC, Graff-Radford NR. Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin Proc. 2001;76:906–9.10.1016/S0025-6196(11)62109-5Search in Google Scholar PubMed

[8] Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. J Am Med Assoc. 2002;288:2123–9.10.1001/jama.288.17.2123Search in Google Scholar

[9] Robusto-Leitao O, Ferreira H. Hormones and dementia – a comparative study of hormonal impairment in post-menopausal women, with and without dementia. Neuropsychiatr Dis Treat. 2006;2:199–206.10.2147/nedt.2006.2.2.199Search in Google Scholar PubMed

[10] Garcia-Segura LM, Azcoitia I, DonCarlos LL. Neuroprotection by estradiol. Prog Neurobiol. 2001;63:29–60.10.1016/S0301-0082(00)00025-3Search in Google Scholar PubMed

[11] Singer CA, Rogers KL, Dorsa DM. Modulation of Bcl-2 expression: a potential component of estrogen protection in NT2 neurons. Neuroreport. 1998;9:2565–8.10.1097/00001756-199808030-00025Search in Google Scholar PubMed

[12] Bonnefont AB, Munoz FJ, Inestrosa NC. Estrogen protects neuronal cells from the cytotoxicity induced by acetylcholinesterase-amyloid complexes. FEBS Lett. 1998;441:220–4.10.1016/S0014-5793(98)01552-XSearch in Google Scholar PubMed

[13] Trinh N-H, Hoblyn J, Mohanty S, Yaffe K. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. J Am Med Assoc. 2003;289:210–6.10.1001/jama.289.2.210Search in Google Scholar

[14] Kritz-Silverstein D, Von Muhlen D, Barrett-Connor E, Bressel MAB. Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study. Menopause. 2003;10:196–202.10.1097/00042192-200310030-00004Search in Google Scholar PubMed

[15] Lund TD, West TW, Tian LY, Bu LH, Simmons DL, Setchell KD, et al. Visual spatial memory is enhanced in female rats (but inhibited in males) by dietary soy phytoestrogens. BMC Neurosci. 2001;2:20.10.1186/1471-2202-2-20Search in Google Scholar PubMed

[16] Soni M, White LR, Kridawati A, Bandelow S, Hogervorst E. Phytoestrogen consumption and risk for cognitive decline and dementia: with consideration of thyroid status and other possible mediators. J Steroid Biochem Mol Biol. 2016;160:67–77.10.1016/j.jsbmb.2015.10.024Search in Google Scholar PubMed

[17] Hogervorst E, Kassam S, Kridawati A, Soni M, Xin X, Shifu X, et al. Nutrition research in cognitive impairment/dementia, with a focus on soya and folate. Proc Nutr Soc. 2017;76(4):737–42.10.1017/S0029665117000404Search in Google Scholar

[18] Gleason CE, Carlsson CM, Barnet JH, Meade SA, Setchell KD, Atwood CS, et al. A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women. Age Ageing. 2008;38:86–93.10.1093/ageing/afn227Search in Google Scholar PubMed

[19] Cheng P-F, Chen J-J, Zhou X-Y, Ren Y-F, Huang W, Zhou J-J, et al. Do soy isoflavones improve cognitive function in postmenopausal women? A meta-analysis. Menopause. 2015;22:198–206.10.1097/GME.0000000000000290Search in Google Scholar PubMed

[20] Duffy R, Wiseman H, File SE. Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones. Pharmacol Biochem Behav. 2003;75:721–9.10.1016/S0091-3057(03)00116-3Search in Google Scholar PubMed

[21] Wang Q, Ge X, Tian X, Zhang Y, Zhang J, Zhang P. Soy isoflavone: the multipurpose phytochemical (Review). Biomed Rep. 2013;1:697–701.10.3892/br.2013.129Search in Google Scholar PubMed

[22] Bagheri M, Joghataei M-T, Mohseni S, Roghani M. Genistein ameliorates learning and memory deficits in amyloid beta(1–40) rat model of Alzheimer’s disease. Neurobiol Learn Mem. 2011;95:270–6.10.1016/j.nlm.2010.12.001Search in Google Scholar PubMed

[23] Lee Y-B, Lee HJ, Won MH, Hwang IK, Kang T-C, Lee J-Y, et al. Soy isoflavones improve spatial delayed matching-to-place performance and reduce cholinergic neuron loss in elderly male rats. J Nutr. 2004;134:1827–31.10.1093/jn/134.7.1827Search in Google Scholar PubMed

[24] Ebrahimzadeh Bideskan AR, Hosseini M, Mohammadpour T, Karami R, Khodamoradi M, Nemati Karimooy H, et al. Effects of soy extract on pentylenetetrazol-induced seizures in ovariectomized rats. Zhong Xi Yi Jie He Xue Bao. 2011;9:611–8.10.3736/jcim20110606Search in Google Scholar PubMed

[25] Mohammadpour T, Hosseini M, Karami R, Sadeghnia HR, Ebrahimzadeh Bideskan AR, Enayatfard L. Estrogen-dependent effect of soy extract on pentylenetetrazole-induced seizures in rats. Zhong Xi Yi Jie He Xue Bao. 2012;10:1470–6.10.3736/jcim20121221Search in Google Scholar PubMed

[26] Vafaee F, Hosseini M, Sadeghinia HR, Hadjzadeh MA, Soukhtanloo M, Rahimi M. The effects of soy extract on spatial learning and memory damage induced by global ischemia in ovariectomised rats. Malays J Med Sci. 2014;21:19–30.Search in Google Scholar PubMed

[27] Hosseini M, Sadeghnia HR, Salehabadi S, Alavi H, Gorji A. The effect of L-arginine and L-NAME on pentylenetetrazole induced seizures in ovariectomized rats, an in vivo study. Seizure. 2009;18:695–8.10.1016/j.seizure.2009.09.008Search in Google Scholar

[28] Hejazian SH, Karimi S, Hosseini M, Mousavi SM, Soukhtanloo M. Protection against brain tissues oxidative damage as a possible mechanism for improving effects of low doses of estradiol on scopolamine-induced learning and memory impairments in ovariectomized rats. Adv Biomed Res. 2016;5:123.10.4103/2277-9175.186981Search in Google Scholar PubMed

[29] Karimi S, Hejazian SH, Alikhani V, Hosseini M. The effects of tamoxifen on spatial and nonspatial learning and memory impairments induced by scopolamine and the brain tissues oxidative damage in ovariectomized rats. Adv Biomed Res. 2015;4:196.10.4103/2277-9175.166132Search in Google Scholar PubMed

[30] Ghasemi S, Moradzadeh M, Hosseini M, Beheshti F, Sadeghnia HR. Beneficial effects of Urtica dioica on scopolamine-induced memory impairment in rats: protection against acetylcholinesterase activity and neuronal oxidative damage. Drug Chem Toxicol. 2018;42:167–75.10.1080/01480545.2018.1463238Search in Google Scholar PubMed

[31] Mokhtari-Zaer A, Hosseini M, Boskabady MH. The effects of exercise on depressive- and anxiety-like behaviors as well as lung and hippocampus oxidative stress in ovalbumin-sensitized juvenile rats. Respir Physiol Neurobiol. 2018;248:55–62.10.1016/j.resp.2017.12.001Search in Google Scholar PubMed

[32] Madesh M, Balasubramanian KA. Microtiter plate assay for superoxide dismutase using MTT reduction by superoxide. Indian J Biochem Biophys. 1998;35:184–8.Search in Google Scholar PubMed

[33] Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121–6.10.1016/S0076-6879(84)05016-3Search in Google Scholar PubMed

[34] Ghorani V, Marefati N, Shakeri F, Rezaee R, Boskabady M, Boskabady MH. The Effects of Allium Cepa Extract on Tracheal Responsiveness, Lung Inflammatory Cells and Phospholipase A2 Level in Asthmatic Rats. Iran J Allergy Asthma Immunol. 2018;17(3):221–31.Search in Google Scholar PubMed

[35] Jung WY, Kim H, Park HJ, Jeon SJ, Park HJ, Choi HJ, et al. The ethanolic extract of the Eclipta prostrata L. ameliorates the cognitive impairment in mice induced by scopolamine. J Ethnopharmacol. 2016;190:165–73.10.1016/j.jep.2016.06.010Search in Google Scholar PubMed

[36] Azizi-Malekabadi H, Hosseini M, Soukhtanloo M, Sadeghian R, Fereidoni M, Khodabandehloo F. Different effects of scopolamine on learning, memory, and nitric oxide metabolite levels in hippocampal tissues of ovariectomized and sham-operated rats. Arq Neuropsiquiatr. 2012;70:447–52.10.1590/S0004-282X2012000600012Search in Google Scholar PubMed

[37] Jamialahmadi K, Sadeghnia HR, Mohammadi G, Kazemabad AM, Hosseini M. Glucosamine alleviates scopolamine induced spatial learning and memory deficits in rats. Pathophysiology. 2013;20:263–7.10.1016/j.pathophys.2013.04.003Search in Google Scholar PubMed

[38] Souza AC, Bruning CA, Acker CI, Neto JS, Nogueira CW. 2-Phenylethynyl-butyltellurium enhances learning and memory impaired by scopolamine in mice. Behav Pharmacol. 2013;24:249–54.10.1097/FBP.0b013e32836353a5Search in Google Scholar PubMed

[39] Hosseini M, Mohammadpour T, Karami R, Rajaei Z, Sadeghnia HR, Soukhtanloo M. Effects of the hydro-alcoholic extract of Nigella sativa on scopolamine-induced spatial memory impairment in rats and its possible mechanism. Chin J Integr Med. 2015;21:438–44.10.1007/s11655-014-1742-5Search in Google Scholar PubMed

[40] Riedel G, Kang SH, Choi DY, Platt B. Scopolamine-induced deficits in social memory in mice: reversal by donepezil. Behav Brain Res. 2009;204:217–25.10.1016/j.bbr.2009.06.012Search in Google Scholar PubMed

[41] Kaur R, Parveen S, Mehan S, Khanna D, Kalra S. Neuroprotective effect of ellagic acid against chronically scopolamine induced Alzheimer’s type memory and cognitive dysfunctions: possible behavioural and biochemical evidences. Int J Prevent Med Res. 2015;1:45–64.Search in Google Scholar

[42] Mohammadpour T, Hosseini M, Naderi A, Karami R, Sadeghnia HR, Soukhtanloo M, et al. Protection against brain tissues oxidative damage as a possible mechanism for the beneficial effects of Rosa damascena hydroalcoholic extract on scopolamine induced memory impairment in rats. Nutr Neurosci. 2015;18:329–36.10.1179/1476830514Y.0000000137Search in Google Scholar PubMed

[43] Ko Y-H, Kim SY, Lee S-Y, Jang C-G. 6,7,4′-Trihydroxyisoflavone, a major metabolite of daidzein, improves learning and memory via the cholinergic system and the p-CREB/BDNF signaling pathway in mice. Eur J Pharmacol. 2018;826:140–7.10.1016/j.ejphar.2018.02.048Search in Google Scholar PubMed

[44] El-Sherbiny DA, Khalifa AE, Attia AS, Eldenshary EE. Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacol Biochem Behav. 2003;76:525–33.10.1016/j.pbb.2003.09.014Search in Google Scholar PubMed

[45] Kim M-S, Lee DY, Lee J, Kim HW, Sung SH, Han J-S, et al. Terminalia chebula extract prevents scopolamine-induced amnesia via cholinergic modulation and anti-oxidative effects in mice. BMC Complement Altern Med. 2018;18:136.10.1186/s12906-018-2212-ySearch in Google Scholar PubMed PubMed Central

[46] McEwen BS. Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol. 2001;91:2785–801.10.1152/jappl.2001.91.6.2785Search in Google Scholar

[47] Daniel JM, Lee CD. Estrogen replacement in ovariectomized rats affects strategy selection in the Morris water maze. Neurobiol Learn Mem. 2004;82:142–9.10.1016/j.nlm.2004.06.001Search in Google Scholar PubMed

[48] Plamondon H, Morin A, Charron C. Chronic 17beta-estradiol pretreatment and ischemia-induced hippocampal degeneration and memory impairments: a 6-month survival study. Horm Behav. 2006;50:361–9.10.1016/j.yhbeh.2006.04.006Search in Google Scholar PubMed

[49] Maki P, Hogervorst E. The menopause and HRT. HRT and cognitive decline. Best Pract Res Clin Endocrinol Metab. 2003;17:105–22.10.1016/S1521-690X(02)00082-9Search in Google Scholar PubMed

[50] Pourganji M, Hosseini M, Soukhtanloo M, Zabihi H, Hadjzadeh MA. Protective role of endogenous ovarian hormones against learning and memory impairments and brain tissues oxidative damage induced by lipopolysaccharide. Iran Red Crescent Med J. 2014;16:e13954.10.5812/ircmj.13954Search in Google Scholar PubMed

[51] Saffarzadeh F, Eslamizade M, Nemati Karimooy H, Hadjzadeh M, Khazaei M, Hosseini M. The effect of L-Arginin on Morris water maze tasks of ovariectomized rats. Acta Physiol Hung. 2010;97:216–23.10.1556/APhysiol.97.2010.2.8Search in Google Scholar PubMed

[52] Khodabandehloo F, Hosseini M, Rajaei Z, Soukhtanloo M, Farrokhi E, Rezaeipour M. Brain tissue oxidative damage as a possible mechanism for the deleterious effect of a chronic high dose of estradiol on learning and memory in ovariectomized rats. Arq Neuropsiquiatr. 2013;71:313–9.10.1590/0004-282X20130027Search in Google Scholar PubMed

[53] Sadeghian R, Fereidoni M, Soukhtanloo M, Azizi-Malekabadi H, Hosseini M. Decreased nitric oxide levels in the hippocampus may play a role in learning and memory deficits in ovariectomized rats treated by a high dose of estradiol. Arq Neuropsiquiatr. 2012;70:874–9.10.1590/S0004-282X2012001100010Search in Google Scholar PubMed

[54] Raghava N, Das BC, Ray SK. Neuroprotective effects of estrogen in CNS injuries: insights from animal models. Neurosci neuroeconomics. 2017;6:15–29.10.2147/NAN.S105134Search in Google Scholar

[55] Sugishita K, Li F, Su Z, Barry WH. Anti-oxidant effects of estrogen reduce [Ca2+]i during metabolic inhibition. J Mol Cell Cardiol. 2003;35:331–6.10.1016/S0022-2828(03)00017-8Search in Google Scholar PubMed

[56] Qian M, Engler-Chiurazzi EB, Lewis SE, Rath NP, Simpkins JW, Covey DF. Structure-activity studies of non-steroid analogues structurally-related to neuroprotective estrogens. Org Biomol Chem. 2016;14:9790–805.10.1039/C6OB01726FSearch in Google Scholar PubMed

[57] Prokai L, Prokai-Tatrai K, Perjesi P, Zharikova AD, Perez EJ, Liu R, et al. Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proc Natl Acad Sci USA. 2003;100:11741–6.10.1073/pnas.2032621100Search in Google Scholar PubMed PubMed Central

[58] Kang J, Badger TM, Ronis MJ, Wu X. Non-isoflavone phytochemicals in soy and their health effects. J Agric Food Chem. 2010;58:8119–33.10.1021/jf100901bSearch in Google Scholar PubMed

[59] Cederroth CR, Nef S. Soy, phytoestrogens and metabolism: a review. Mol Cell Endocrinol. 2009;304:30–42.10.1016/j.mce.2009.02.027Search in Google Scholar PubMed

[60] Luine V, Attalla S, Mohan G, Costa A, Frankfurt M. Dietary phytoestrogens enhance spatial memory and spine density in the hippocampus and prefrontal cortex of ovariectomized rats. Brain Res. 2006;1126:183–7.10.1016/j.brainres.2006.07.016Search in Google Scholar PubMed

[61] Casini ML, Marelli G, Papaleo E, Ferrari A, D’Ambrosio F, Unfer V. Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: a randomized, double-blind, crossover, placebo-controlled study. Fertil Steril. 2006;85:972–8.10.1016/j.fertnstert.2005.09.048Search in Google Scholar PubMed

[62] Fournier LR, Ryan Borchers TA, Robison LM, Wiediger M, Park JS, Chew BP, et al. The effects of soy milk and isoflavone supplements on cognitive performance in healthy, postmenopausal women. J Nutr Health Aging. 2007;11:155–64.Search in Google Scholar PubMed

[63] Xiao CW. Health effects of soy protein and isoflavones in humans. J Nutr. 2008;138:1244S–9S.10.1093/jn/138.6.1244SSearch in Google Scholar PubMed

[64] Engelman HM, Alekel DL, Hanson LN, Kanthasamy AG, Reddy MB. Blood lipid and oxidative stress responses to soy protein with isoflavones and phytic acid in postmenopausal women. Am J Clin Nutr. 2005;81:590–6.10.1093/ajcn/81.3.590Search in Google Scholar PubMed

[65] Ekor M, Emerole GO, Farombi EO. Phenolic extract of soybean (glycine max) attenuates cisplatin-induced nephrotoxicity in rats. Food Chem Toxicol. 2010;48:1005–12.10.1016/j.fct.2009.12.027Search in Google Scholar PubMed

[66] Lu C, Wang Y, Wang D, Zhang L, Lv J, Jiang N, et al. Neuroprotective effects of soy isoflavones on scopolamine-induced amnesia in mice. Nutrients. 2018;10(7). DOI: 10.3390/nu10070853.Search in Google Scholar PubMed PubMed Central

Received: 2018-12-29
Accepted: 2019-05-03
Published Online: 2019-09-04

© 2019 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 6.6.2024 from https://www.degruyter.com/document/doi/10.1515/hmbci-2018-0084/html
Scroll to top button